Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Sabine E. Grimm*, Debra Fayter, Bram L. T. Ramaekers, Svenja Petersohn, Rob Riemsma, Nigel Armstrong, Xavier Pouwels, Willem Witlox, Caro Noake, Gillian Worthy, Jos Kleijnen, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)1195-1207
Number of pages13
JournalPharmacoeconomics
Volume37
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • BRENTUXIMAB VEDOTIN
  • HEALTH
  • DESIGN

Cite this

@article{882bd767ae3d401e930e7a72905212d8,
title = "Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
keywords = "BRENTUXIMAB VEDOTIN, HEALTH, DESIGN",
author = "Grimm, {Sabine E.} and Debra Fayter and Ramaekers, {Bram L. T.} and Svenja Petersohn and Rob Riemsma and Nigel Armstrong and Xavier Pouwels and Willem Witlox and Caro Noake and Gillian Worthy and Jos Kleijnen and Joore, {Manuela A.}",
year = "2019",
month = "10",
doi = "10.1007/s40273-019-00792-7",
language = "English",
volume = "37",
pages = "1195--1207",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "10",

}

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma : An Evidence Review Group Perspective of a NICE Single Technology Appraisal. / Grimm, Sabine E.; Fayter, Debra; Ramaekers, Bram L. T.; Petersohn, Svenja; Riemsma, Rob; Armstrong, Nigel; Pouwels, Xavier; Witlox, Willem; Noake, Caro; Worthy, Gillian; Kleijnen, Jos; Joore, Manuela A.

In: Pharmacoeconomics, Vol. 37, No. 10, 10.2019, p. 1195-1207.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma

T2 - An Evidence Review Group Perspective of a NICE Single Technology Appraisal

AU - Grimm, Sabine E.

AU - Fayter, Debra

AU - Ramaekers, Bram L. T.

AU - Petersohn, Svenja

AU - Riemsma, Rob

AU - Armstrong, Nigel

AU - Pouwels, Xavier

AU - Witlox, Willem

AU - Noake, Caro

AU - Worthy, Gillian

AU - Kleijnen, Jos

AU - Joore, Manuela A.

PY - 2019/10

Y1 - 2019/10

KW - BRENTUXIMAB VEDOTIN

KW - HEALTH

KW - DESIGN

U2 - 10.1007/s40273-019-00792-7

DO - 10.1007/s40273-019-00792-7

M3 - Review article

VL - 37

SP - 1195

EP - 1207

JO - Pharmacoeconomics

JF - Pharmacoeconomics

SN - 1170-7690

IS - 10

ER -